NCT02653963View on ClinicalTrials.gov

Triamcinolone for Ahmed Glaucoma Valve

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

December 31, 2016

Conditions
Glaucoma
Interventions
DRUG

Adjunctival Triamcinolone

Intraoperative Periplate 10 mg Triamcinolone Injection during AGV Implantation

Trial Locations (1)

16666

Ophthalmic Research Center, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve | Biotech Hunter | Biotech Hunter